Necrotizing leg gangrene from invasive cutaneous Kaposi sarcoma, reversed by pegylated liposomal doxorubicin

1, 1, 2, 3, 4, 5

1Department of Internal Medicine, Eisenhower Health, Rancho Mirage, CA, USA

2Floyd and Delores Jones Cancer Institute, Virginia Mason Medical Center, Seattle, WA, USA

3Division of Hematology, University of Washington School of Medicine, Seattle, WA, USA

4Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA

5Department of Medical Oncology and Hematology, University of California in San Diego Health System, San Diego, CA, USA


We certify that we do not have any affiliation with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript (e.g. employment, consultancies, stock ownership, honoraria, and expert testimony). We do not have any commercial or proprietary interest in any drug, device, or equipment mentioned in the article below. No financial support was used for this work. No previously published figures or tables were used in this paper. We certify sufficient participation of each author in the conception, design, analysis, interpretation, writing, revising, and approval of the manuscript. -- The Authors

Corresponding Author:

Catherine B. Goff, Department of Internal Medicine, Eisenhower Health, 39000 Bob Hope Dr, ACHS Building 2nd Floor, Rancho Mirage, CA, 92270, USA. Email:

留言 (0)

沒有登入
gif